World-class research. Ultimate impact.
More on impact ›
Frontiers in Genome Editing is a multidisciplinary, open-access journal which publishes rigorously peer-reviewed research and disseminates scientific knowledge to researchers, academics, policy makers and the public worldwide. The journal aims to address the advances in genome and epigenome editing technologies and their implications in research and clinical translation, thereby stimulating cutting-edge research and communicating impactful discoveries to industry. The journal publishes research in existing and emerging gene editing technologies including CRISPR/Cas systems, ZFNs, TALENs, meganucleases...
Our specialty sections include:
Short Name: Front. Genome Ed.
Electronic ISSN: 2673-3439
Indexed in: Google Scholar, CrossRef, CLOCKSS, OpenAIRE
Frontiers in Genome Editing is composed of the following Specialty Sections:
The specialty sections of Frontiers in Genome Editing welcome submission of the following article types: Brief Research Report, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review and Specialty Grand Challenge.
When submitting a manuscript to Frontiers in Genome Editing, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Genome Editing.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org